BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shahid I, AlMalki WH, Hassan S, Hafeez MH. Real-world challenges for hepatitis C virus medications: a critical overview. Crit Rev Microbiol 2018;44:143-60. [PMID: 28539069 DOI: 10.1080/1040841X.2017.1329277] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Shahid I. Meet our Associate Editorial Board Member. RRCT 2021;16:121-121. [DOI: 10.2174/157488711602210408115709] [Reference Citation Analysis]
2 Trickey A, Sood A, Midha V, Thompson W, Vellozzi C, Shadaker S, Surlikar V, Kanchi S, Vickerman P, May MT, Averhoff F. Clustering of hepatitis C virus antibody positivity within households and communities in Punjab, India. Epidemiol Infect 2019;147:e283. [PMID: 31587676 DOI: 10.1017/S0950268819001705] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kawaguchi T, Komori A, Fujisaki K, Nishiguchi S, Kato M, Takagi H, Tanaka Y, Notsumata K, Mita E, Nomura H, Shibatoge M, Takaguchi K, Hattori T, Sata M, Koike K. Eltrombopag enables initiation and completion of pegylated interferon/ribavirin therapy in Japanese HCV-infected patients with chronic liver disease and thrombocytopenia. Exp Ther Med 2019;18:596-604. [PMID: 31258695 DOI: 10.3892/etm.2019.7616] [Reference Citation Analysis]
4 Kneller DW, Phillips G, Weiss KL, Zhang Q, Coates L, Kovalevsky A. Direct Observation of Protonation State Modulation in SARS-CoV-2 Main Protease upon Inhibitor Binding with Neutron Crystallography. J Med Chem 2021;64:4991-5000. [PMID: 33755450 DOI: 10.1021/acs.jmedchem.1c00058] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]